Literature DB >> 16138009

Low concentrations of taxol cause mitotic delay followed by premature dissociation of p55CDC from Mad2 and BubR1 and abrogation of the spindle checkpoint, leading to aneuploidy.

Amy E Ikui1, Chia-Ping Huang Yang, Tomohiro Matsumoto, Susan Band Horwitz.   

Abstract

Taxol is widely used for the treatment of human cancer. Its mechanism of action in cells is dependent on drug concentration. At low concentrations of Taxol (5-10 nM), cells exhibit aberrant mitosis, including aneuploidy, in the absence of mitotic arrest. At higher concentrations of Taxol (>20 nM), the cell cycle is blocked at metaphase by spindle checkpoint activation. Here we demonstrate that low concentrations of Taxol cause mitotic delay, and result in an aneuploid population of cells after exit from mitosis. Low concentrations of Taxol dissociated p55CDC-Mad2 or p55CDC-BubR1 complexes after mitosis, whereas high concentrations of Taxol sustained the protein complex formation leading to mitotic block. The induction of apoptosis and aneuploidy by low concentrations of Taxol may result from chromosome missegregation caused by spindle checkpoint defects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16138009     DOI: 10.4161/cc.4.10.2061

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  30 in total

Review 1.  Mitosis in vertebrates: the G2/M and M/A transitions and their associated checkpoints.

Authors:  Conly L Rieder
Journal:  Chromosome Res       Date:  2011-04       Impact factor: 5.239

Review 2.  Mitosis as an anti-cancer drug target.

Authors:  Anna-Leena Salmela; Marko J Kallio
Journal:  Chromosoma       Date:  2013-06-18       Impact factor: 4.316

3.  Comparison of cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast cancer cells.

Authors:  Jan Kovár; Marie Ehrlichová; Barbora Smejkalová; Ilaria Zanardi; Iwao Ojima; Ivan Gut
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

4.  Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells.

Authors:  Aniek Janssen; Geert J P L Kops; René H Medema
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-23       Impact factor: 11.205

Review 5.  Nature as a remarkable chemist: a personal story of the discovery and development of Taxol.

Authors:  Mansukh C Wani; Susan Band Horwitz
Journal:  Anticancer Drugs       Date:  2014-05       Impact factor: 2.248

6.  Peloruside A, a microtubule-stabilizing agent, induces aneuploidy in ovarian cancer cells.

Authors:  Ariane Chan; A Jonathan Singh; Peter T Northcote; John H Miller
Journal:  Invest New Drugs       Date:  2016-05-07       Impact factor: 3.850

7.  Paclitaxel effects on the proteome of HL-60 promyelocytic leukemic cells: comparison to peloruside A.

Authors:  Anja Wilmes; Ariane Chan; Pisana Rawson; T William Jordan; John Holmes Miller
Journal:  Invest New Drugs       Date:  2010-09-23       Impact factor: 3.850

8.  Acute Taxol nephrotoxicity: Histological and ultrastructural studies of mice kidney parenchyma.

Authors:  Samar Omar Rabah
Journal:  Saudi J Biol Sci       Date:  2010-02-24       Impact factor: 4.219

9.  The ability to survive mitosis in the presence of microtubule poisons differs significantly between human nontransformed (RPE-1) and cancer (U2OS, HeLa) cells.

Authors:  Daniela A Brito; Conly L Rieder
Journal:  Cell Motil Cytoskeleton       Date:  2009-08

10.  Cells satisfy the mitotic checkpoint in Taxol, and do so faster in concentrations that stabilize syntelic attachments.

Authors:  Zhenye Yang; Alison E Kenny; Daniela A Brito; Conly L Rieder
Journal:  J Cell Biol       Date:  2009-08-31       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.